Susquehanna International Group’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15
Closed -$11K 13679
2022
Q2
$11K Sell
15
-19
-56% -$29.8K ﹤0.01% 12494
2022
Q1
$118K Sell
34
-14
-29% -$36.7K ﹤0.01% 11781
2021
Q4
$145K Sell
48
-6
-11% -$27.8K ﹤0.01% 11827
2021
Q3
$355K Sell
54
-24
-31% -$207K ﹤0.01% 10212
2021
Q2
$1.03M Sell
78
-46
-37% -$723K ﹤0.01% 7678
2021
Q1
$2.08M Buy
124
+30
+32% +$586K ﹤0.01% 5830
2020
Q4
$1.58M Buy
94
+15
+19% +$282K ﹤0.01% 5607
2020
Q3
$1.48M Buy
79
+45
+132% +$1.03M ﹤0.01% 5206
2020
Q2
$905K Buy
+34
New +$963K ﹤0.01% 6148
2020
Q1
Sell
-43
Closed -$687K 10571
2019
Q4
$395K Sell
43
-10
-19% -$96.6K ﹤0.01% 7453
2019
Q3
$503K Buy
+53
New +$645K ﹤0.01% 7296
2017
Q4
Sell
-4
Closed -$222K 9591
2017
Q3
$222K Buy
+4
New +$219K ﹤0.01% 7862

Other funds holding KALA

Susquehanna International Group's KALA Position: Q3 2022 in Review

Susquehanna International Group sold out of KALA BIO (KALA) in Q3 2022, closing a stake of 15 shares — an estimated $11K sold.

Susquehanna International Group first reported a position in KALA in Q3 2017 and held it in 12 quarters. The position peaked at $2.08M in Q1 2021. 53 funds tracked by Wall St. Rank hold KALA as of Q3 2022.

  • Susquehanna International Group reported no remaining KALA BIO position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 15 KALA BIO shares in Q3 2022, an estimated $11K.
  • Susquehanna International Group first reported a position in KALA BIO in Q3 2017 and held it in 12 quarters.
  • Susquehanna International Group's KALA BIO position peaked at $2.08M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held KALA BIO as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.